<p>Data are reported as mean±standard deviation or frequencies (n) and percentages (%), for continuous and categorical variables, respectively.</p><p>GMS: Gargano Mortality Study; FMS: Foggia Mortality Study; BMI: body mass index; LDL: low density lipoprotein; e-GFR: estimated-glomerular filtration rate; OAD: oral antidiabetes drugs.</p><p>Baseline clinical features of 1739 patients with type 2 diabetes from Gargano Mortality Study and Foggia Mortality Study.</p
<p>Data is presented as mean±SD, n(%) or median (25th;75th percentile)</p><p><sup>a</sup> Leucocyte ...
<p>JDS, Japan Diabetes Society.</p><p>Data are expressed as mean (standard deviation), median (25 pe...
<p> = 715.<sup></sup> Cohort size: n</p><p>±SD or percentages. ND = not determined. A1C: glycated h...
<p>Data are reported as mean ± standard deviation or number (percent) or median [1<sup>st</sup>, 3<s...
<p>Main clinical characteristics and metabolic data at baseline (day 1) and discharge (day 5) of typ...
<p>Data is presented as mean±SD or n (%). B: blood, S: serum, P: plasma, ACE: Angiotensin converting...
<p>Mean and ± standard deviation are shown for continuous variables. Age, triglycerides, HbA<sub>1c<...
<p>Seven patients were lost to follow-up and did not define the baseline characteristics of the surv...
<p>Data are presented as number (percentage) for categorical data, mean (standard deviation) for par...
<p>Data are presented as number (percentage) for categorical data, mean (standard deviation) for par...
<p>Baseline characteristics of diabetes cases, pre-diabetes cases and non-cases in the Rancho Bernar...
<p>Baseline characteristics of study participants by diabetes status (<i>n</i> = 122,402).</p
<p>Baseline characteristics of type 2 diabetes patients who initiated GLP-1 receptor agonists (GLP-1...
<p>* We fractionated baseline HbA<sub>1c</sub> levels into ≤5.5%, 5.6–5.9% and 6.0–6.4%, and evaluat...
<p>Abbreviations: TIA transient ischemic attack, SD standard deviation, IQR interquartile range, HbA...
<p>Data is presented as mean±SD, n(%) or median (25th;75th percentile)</p><p><sup>a</sup> Leucocyte ...
<p>JDS, Japan Diabetes Society.</p><p>Data are expressed as mean (standard deviation), median (25 pe...
<p> = 715.<sup></sup> Cohort size: n</p><p>±SD or percentages. ND = not determined. A1C: glycated h...
<p>Data are reported as mean ± standard deviation or number (percent) or median [1<sup>st</sup>, 3<s...
<p>Main clinical characteristics and metabolic data at baseline (day 1) and discharge (day 5) of typ...
<p>Data is presented as mean±SD or n (%). B: blood, S: serum, P: plasma, ACE: Angiotensin converting...
<p>Mean and ± standard deviation are shown for continuous variables. Age, triglycerides, HbA<sub>1c<...
<p>Seven patients were lost to follow-up and did not define the baseline characteristics of the surv...
<p>Data are presented as number (percentage) for categorical data, mean (standard deviation) for par...
<p>Data are presented as number (percentage) for categorical data, mean (standard deviation) for par...
<p>Baseline characteristics of diabetes cases, pre-diabetes cases and non-cases in the Rancho Bernar...
<p>Baseline characteristics of study participants by diabetes status (<i>n</i> = 122,402).</p
<p>Baseline characteristics of type 2 diabetes patients who initiated GLP-1 receptor agonists (GLP-1...
<p>* We fractionated baseline HbA<sub>1c</sub> levels into ≤5.5%, 5.6–5.9% and 6.0–6.4%, and evaluat...
<p>Abbreviations: TIA transient ischemic attack, SD standard deviation, IQR interquartile range, HbA...
<p>Data is presented as mean±SD, n(%) or median (25th;75th percentile)</p><p><sup>a</sup> Leucocyte ...
<p>JDS, Japan Diabetes Society.</p><p>Data are expressed as mean (standard deviation), median (25 pe...
<p> = 715.<sup></sup> Cohort size: n</p><p>±SD or percentages. ND = not determined. A1C: glycated h...